Samples for your research and development

We offer various samples for research, including single donations (panels and bulks) for the validation of test systems. For this purpose, a selection of standard products with various indications such as Type I Type II is available.

The in.vent products are for research or manufacturing purposes only and are therefore not intended for direct therapeutic or diagnostic use in humans or animals. Furthermore, we follow the highest ethical standards in the procurement of samples. If you have any questions in this regard, please do not hesitate to contact us!

Why is research into diabetes important?

Worldwide, approximately 425 million people suffer from this illness. If the numbers  as feared by the IDF (International Diabetes Federation) increase, there could be about 629 million worldwide in 2045.

Type I: is a chronic autoimmune disease with an absolute insulin deficiency. The body’s own immune system destroys the insulin-producing β cells of the pancreas.

Type II: is a disorder in which insulin is present, but cannot work properly at its destination, the cell membranes (so-called insulin resistance).

Our portfolio includes the following Biomarkers:

  • Insulin Autoantibodies (IAA)
  • Icelet Cell Antibodies (ICA)
  • Glutamate-Decarboxylase Antibodies (GADA)
  • Tyrosine-Phoasphatase Antibodies (IA2)

Composition and documentation of Diabetes samples

Our samples consist of native human bio-material without additives. All titres are based on current availability. In addition, we provide detailed information for each product, including: titer, volume, matrix, shelf life, test kit and test manufacturer. For single donors, we also add information such as age, gender of the donor and the measured laboratory result.

Furthermore, you have the possibility to send us individual enquiries regarding matrix, volume and biomarker. Our Inquiry Form is available for this purpose.


  • Die betriebliche Innovation soll zur Entwicklung von neuartigen Produkten, Standardmaterialien und Standard-Services (PMS) für den proaktiven Vertrieb am diagnostischen Weltmarkt führen. Produkte und Standardmaterialien werden in die firmeneigene Website und das interne digitale Projektmanagement-Betriebssystem (CRM) implementiert“
  • Ziel ist es, die Entwicklung und Etablierung dieser Produkte und die Etablierung dieses Prozesses im Allgemeinen innerhalb von zwei Jahren abzuschließen. Der Prozess muss dynamisch reproduzierbar sein. Bestehende PMS bedürfen des regelmäßigen Monitorings.
Qualification measures:

Growing Organisation; Adaption of Qualification to new market demands, project areas and fields of production

To achieve the goal, that invent persist at the international market, qualification for current and new employees were conducted as follows:

  • training in online-marketing,
  • in contract law and
  • in business basics for executive leadership with scientific background.

New employees acquired competences in the fields of:

  • data protection,
  • medical devices advice,
  • internal auditing,
  • performance assessment of in-vitro diagnostics as well as
  • project management

In the field of production, knowledge of macro programming was gained for digitization.

The measures were funded through the European Social Fund and the state of Brandenburg for the period 2019 – 2021.